University of Maryland, Baltimore (UMB)
A postdoctoral or research associate position is available to study targeted therapy in cancer. Our goal is to investigate the mechanisms for development of chemoresistance and find new therapies for the treatment of relapse and chemotherapy resistant prostate cancer and head & neck cancer. The efficacy of the combination treatment will be tested in relevant preclinical models in vitro and in animal including xenograft and PDX. Interested candidates must possess a Ph.D. along with relevant experience in cancer biology or a related field. Priority will be given to candidates with experience in signal transduction and drug resistance. Candidates are expected to have extensive hands-on experience in cell culture (2D and 3D), cellular proliferation assay and determination of IC50 and combination index values (CI), protein expression and purification, protein-interaction studies, Western blotting, real-time PCR, flow cytometry, and immunohistochemistry. Experience with handling mice is desired, but not required. Interested candidates should e-mail their curriculum vitae and contact information for three references to: Hancai Dan, Associate Professor, University of Maryland Greenebaum Comprehensive Cancer Center, e-mail: Hdan@som.umaryland.edu
為防止簡歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國博士人才網(wǎng)）
中國-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
